免疫细胞在慢性乙型肝炎免疫耐受机制中的作用

李俊卿; 周俊英

免疫细胞在慢性乙型肝炎免疫耐受机制中的作用

河北医科大学第三医院感染科

详细信息

中图分类号: R512.62
计量
- 文章访问数: 4202
- HTML全文浏览量: 15
- PDF下载量: 1389
- 被引次数: 0
出版历程
- 出版日期: 2011-04-20

The role of immune cells in immune tolerance mechanisms towards chronic hepatitis B

摘要

摘要: 机体对乙型肝炎病毒(HBV)的免疫耐受是HBV感染慢性化的主要机制。急性、自限性HBV感染过程中存在强烈的、多特异性的细胞免疫应答。而在慢性感染者这种反应明显减弱,存在免疫耐受。本文旨在阐述免疫细胞在HBV免疫耐受机制中可能发挥的作用。
- 肝炎病毒,乙型 /
- 免疫耐受 /
- 树突细胞 /
- T淋巴细胞,辅助诱导 /
- T淋巴细胞 /
- 肝炎,乙型,慢性
Abstract: Immune tolerance to hepatitis B virus (HBV) is the major chronicity mechanism of HBV infection.Cell-mediated immune responses to HBV antigens are vigorous and multispecific in acute, self-limited infections, whereas in chronic infection the response was significantly attenuated with immune tolerance.In this article, the role of immune cells in the mechanisms of immune tolerance was reviewed.
- hepatitis B virus /
- immune tolerance /
- dendritic cells /
- T-lymphocytes /
- helper-inducer /
- T-lymphocytes

HTML全文

参考文献(22)

[1]Chisari FV, Isogawa M, Wieland SF.Pathogenesis of hepatitis Bvirus infection[J].Pathol Biol, 2010, 58 (4) :258-266.

[2]Ito H, Ando K, Ishikawa T, et al.Role of Valpha14+NKTcells in the development of Hepatitis B virus-specific CTL:activation of Valpha14+NKT cells promotes the breakage ofCTL tolerance[J].Int Immunol, 2008, 20 (7) :869-879.

[3]Chen W, Shi M, Shi F, et al.HBcAg-pulsed dendritic cellvaccine induces Th1 polarization and production of hepatitisB virus-specific cytotoxic T lymphocytes[J].Hepatol Res, 2009, 39 (4) :355-365.

[4]Andrade F.Non-cytotoxic antiviral activities of granzymesin the context of the immune antiviral state[J].Immunol Rev, 2010, 235 (1) :128-146.

[5]Sprengers D, van der Molen RG, Kusters JG, et al.Analysisof intrahepatic HBV-specific cytotoxic T-cells during andafter acute HBV infection in humans[J].J Hepatol, 2006, 45 (2) :182-189.

[6]Rehermann B.Chronic infections with hepatotropic viruses:mechanisms of impairment of cellular immune responses[J].Semin Liver Dis, 2007, 27 (2) :152-160.

[7]Barber DL, Wherry EJ, Masopust D, et al.Restoring functionin exhausted CD8 T cells during chronic viral infection[J].Nature, 2006, 439 (7077) :682-687.

[8]Evans A, Riva A, Cooksley H, et al.Programmed death 1expression during antiviral treatment of chronic hepatitisB:Impact of hepatitis B e-antigen seroconversion[J].Hepatology, 2008, 48 (3) :759-769.

[9]Akbar SM, Yoshida O, Chen S, et al.Immune modulator andantiviral potential of dendritic cells pulsed with both hepatitisB surface antigen and core antigen for treating chronic HBVinfection[J].Antivir Ther, 2010, 15 (6) :887-895.

[10]Zhang Z, Zhang H, Chen D, et al.Response to interferon-alpha treatment correlates with recovery of bloodplasmacytoid dendritic cells in children with chronic hepatitisB[J].J Hepatol, 2007, 47 (6) :751-759.

[11]Carotenuto P, Artsen A, Niesters HG, et al.In vitro useof autologous dendritic cells improves detection of T cellresponses to hepatitis B virus (HBV) antigens[J].J Med Virol, 2009, 81 (2) :332-339.

[12]Op den Brouw ML, Binda RS, van Roosmalen MH, et al.Hepatitis B virus surface antigen impairs myeloid dendriticcell function:a possible immune escape mechanism ofhepatitis B virus[J].Immunology, 2009, 126 (2) :280-289.

[13]Shi M, Fu J, Shi F, et al.Viral suppression correlates withdendritic cell restoration in chronic hepatitis B patients withautologous cytokine-induced killer cell transfusion[J].LiverInt, 2009, 29 (3) :466-474.

[14]Zhang Z, Zou ZS, Fu JL, et al.Severe dendritic cellperturbation is actively involved in the pathogenesis ofacute-on-chronic hepatitis B liver failure[J].J Hepatol, 2008, 49 (3) :396-406.

[15]Gately MK, Gubler U, Brunda MJ, et al.Interleukin-12:acytokine with therapeutic potential in oncology and infectiousdiseases[J].Ther Immunol, 1994, 1 (3) :187-196.

[16]Wilson EB, Brooks DG.The Role of IL-10 in RegulatingImmunity to Persistent Viral Infections[J].Curr Top MicrobiolImmunol, 2010.[Epub ahead of print]

[17]Loggi E, Gramenzi A, Margotti M, et al.In vitro effect ofthymosin-alpha1 and interferon-alpha on Th1 and Th2cytokine synthesis in patients with eAg-negative chronichepatitis B[J].J Viral Hepat, 2008, 15 (6) :442-448.

[18]Wu JF, Wu TC, Chen CH, et al.Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis Bvirus e antigen seroconversion[J].Gastroenterology, 2010, 138 (1) :165-172.

[19]Lu GF, Tang FA, Zheng PY, et al.Entecavir up-regulatesdendritic cell function in patients with chronic hepatitis B[J].World J Gastroenterol, 2008, 14 (10) :1617-1621.

[20]Stoop JN, van der Molen RG, Baan CC, et al.Regulatory Tcells contribute to the impaired immune response in patientswith chronic hepatitis B virus infection[J].Hepatology, 2005, 41 (4) :771-778.

[21]Feng IC, Koay LB, Sheu MJ, et al.HBcAg-specific CD4+CD25+regulatory T cells modulate immune tolerance and acuteexacerbation on the natural history of chronic hepatitis B virusinfection[J].J Biomed Sci, 2007, 14 (1) :43-57.

[22]Kondo Y, Ueno Y, Kobayashi K, et al.Hepatitis B virusreplication could enhance regulatory T cell activityby producing soluble heat shock protein 60 fromhepatocytes[J].J Infect Dis, 2010, 202 (2) :202-213.

施引文献

资源附件(0)

访问统计